Golvatinib Completed Phase 1 Trials for Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00921869A Study of E7050 Administered Orally to Patients With Advanced Solid Tumors